首页 | 本学科首页   官方微博 | 高级检索  
     

血清中人附睾蛋白4、抑制素A及癌胚抗原125联合检测在卵巢癌诊断中的意义
引用本文:王永春,余进进. 血清中人附睾蛋白4、抑制素A及癌胚抗原125联合检测在卵巢癌诊断中的意义[J]. 陕西肿瘤医学, 2012, 0(4): 785-788
作者姓名:王永春  余进进
作者单位:[1]嘉兴市妇幼保健院妇科,浙江嘉兴314000 [2]苏州大学附属第四医院(暨无锡市第四人民医院),江苏无锡214062
摘    要:目的:探讨人附睾蛋白4(HE4)、抑制素A(inhibinA)及癌胚抗原125(CA125)在卵巢癌患者中的诊断价值。方法:应用ELISA法检测卵巢癌组、卵巢良性肿瘤组及正常对照组患者血清中HE4、InhibinA、CA125水平。结果:血清HE4水平:卵巢癌组(133.86±127.94)pmol/L、卵巢良性肿瘤组(42.67±22.77)pmol/L、正常对照组(33.40±19.50)pmol/L;血清InhibinA水平:卵巢癌组(177.22±114.35)ng/L、卵巢良性肿瘤组(76.60±14.10)ng/L、正常对照组(70.70±21.66)ng/L;血清CA125水平:卵巢癌组(750.52±1230.34)U/L、卵巢良性肿瘤组(67.25±106.16)U/L、正常对照组(17.69±6.13)U/L。统计学分析血清HE4、InhibinA数值显示:卵巢癌组与卵巢良性肿瘤组、正常对照组比较,P〈0.05,差异有统计学意义;而卵巢良性肿瘤组与正常对照组比较,P〉0.05,差异无统计学意义。血清CA125卵巢癌组与卵巢良性肿瘤组、正常对照组比较,P〈0.05,差异有统计学意义;良性肿瘤组与正常对照组比较,P〈0.05,差异有统计学意义。卵巢癌诊断中的阳性率分别是:HE4 71.8%、InhibinA 66.7%、CA125 61.5%,三者联合阳性率为92.3%。结论:HE4、InhibinA、CA125在卵巢癌诊断中有重要意义,三者联合检测能明显提高卵巢癌的诊断率。

关 键 词:人附睾蛋白4  抑制素A  CA125  卵巢肿瘤  酶联免疫法

Diagnostic value of serum HE4,InhibinA and CA125 in patients with ovarian cancer
WANG Yongchun,YU Jinjin. Diagnostic value of serum HE4,InhibinA and CA125 in patients with ovarian cancer[J]. Shaanxi Oncology Medicine, 2012, 0(4): 785-788
Authors:WANG Yongchun  YU Jinjin
Affiliation:1 Maternal and Child Care Service Centre of Jiaxing City,Zhejiang Jiaxing 314000,China;2 the Fourth Hospital Affiliated of Soochow University,Jiangsu Wuxi 214062,China.
Abstract:Objective: To detect the level of serum human epididymis4,InhibinA and CA125 in patients with ovarian cancer.Methods: ELISA method was used to test serum HE4,InhibinA and CA125 in ovarian cancer group,benign ovarian tumor group and the healthy control.Results: The serum HE4 level of ovarian cancer group was(133.86 ± 127.94) pmol/L,benign ovarian tumor group was(42.67 ± 22.77) pmol / L,the healthy control was(33.40 ± 19.50) pmol / L;Serum InhibinA level: ovarian cancer group was(177.22 ± 114.35) ng / L,benign ovarian tumor group was(76.60 ±14.10) ng/L,the healthy control was(70.70 ±21.66) ng/L;Serum CA125 level: ovarian cancer group was(750.52 ± 1230.34) U / L,benign ovarian tumor group was(67.25 ± 106.16) U / L,the healthy control was(17.69 ±6.13) U/L.Serum HE4 and InhibinA: comparing with ovarian cancer group,ovarian benign tumor group and normal control group,P 0.05,and ovarian benign tumor group compared with normal control group,P 0.05.For CA125 comparing with ovarian cancer group,ovarian benign tumor group and normal control group,P ﹤ 0.05,the difference was statistically significant,benign tumor group compared with normal control group,P 0.05.The positive rate were: HE4 70.59%,InhibinA 66.7%,CA125 63.3%,the positive rate of combination was 93.3%.Conclusion: HE4,InhibinA,CA125 have important significance in the diagnosis of ovarian cancer,combination of these three markers can raise up the positive rate of diagnose of ovarian cancer.
Keywords:human epididymis protein 4  InhibinA  CA125  ovarian neopiasms  enzyme linked immunosorbent assay
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号